FDA Approves Restylane
On December 12, 2003, the U.S. Food and Drug Administration (FDA) approved Restylane®, an injection for the correction of moderate to severe facial wrinkles. Restylane is the first and only FDA-approved cosmetic filler made of a biodegradable non-animal hyaluronic acid. Hyaluronic acid is a natural sugar based substance found in all living organisms and provides volume and fullness to the skin.
Charles E. Crutchfield III, MD, the Director of Crutchfield Dermatology and Board Certified Dermatologist commented “Restylane is probably the most exciting non-surgical advancement in wrinkle reduction and cosmetic facial rejuvenation today. While there are numerous injectable fillers on the market (such as collagen and many others), many of them have their drawbacks ranging from allergic reactions to short life spans. Restylane is very safe and natural”.
When asked about Restylane’s ability to ‘replace Botox’ as the new wrinkle remover, Dr. Crutchfield commented “Restylane compliments the action of Botox Cosmetic, making the results even more dramatic and longer lasting. Botox eliminates wrinkles caused from facial movements. Restylane eliminates wrinkles of the face when it is at rest. The two work beautifully together to make an unbeatable and dramatically effective 1-2 combination for a wrinkle-reduced appearance, with absolutely no down time.”
Dr. Crutchfield is a board certified dermatologist and graduate of the Mayo Clinic Medical School. He is also Clinical Associate Professor of Dermatology at the University of Minnesota Medical School, and Medical Director of Crutchfield Dermatology in Eagan where he has been the leading provider of Restylane and Botox Cosmetic in the United States. Doctor Crutchfield was honored by Minneapolis-St. Paul Magazine as a 2003-2004 ”Top Doctor” in a vote of 5,000 physicians and nurses.
Dr. Crutchfield is an excellent interview and will educate and engage you and your audience. To schedule an interview Dr. Crutchfield call
On December 12, 2003, the U.S. Food and Drug Administration…